Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for UGROCAP.BO and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for UGROCAP.BO and 80,000+ other tickers.
See exactly how UGROCAP.BO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for UGROCAP.BO and 80,000+ other tickers.
UGRO Capital Limited functions as a non-banking financial institution, primarily focusing on lending operations within India and across international markets. This company provides business financing to a broad spectrum of industries, such as healthcare, education, chemicals, food processing and fast-moving consumer goods (FMCG), hospitality, manufacturers of electrical equipment and components, auto components, and light engineering. Established in 1993, the firm was initially known as Chokhani Securities Limited before adopting its current name, Ugro Capital Limited, in September 2018. Its headquarters are located in Mumbai, India.
No recent news available.